ArticleJournal of nanobiotechnology2024

Leveraging adrenergic receptor blockade for enhanced nonalcoholic fatty liver disease treatment via a biomimetic nanoplatform.

Bingyuan Fei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.